Business Description
Nicox SA
ISIN : FR0013018124
Share Class Description:
XPAR:ALCOX: Share from reverse splitCompare
Compare
Traded in other countries / regions
ALCOX.France0RCQ.UKNXOA.GermanyNICXF.USA IPO Date
1999-11-03Description
Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Its lead program in clinical development is NCX 470 (bimatoprost grenod), a novel nitric oxide-donating bimatoprost eye drop, for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company also has a preclinical research program on NCX 1728, a nitric oxide-donating phosphodiesterase-5 inhibitor, with Glaukos. Its first product, VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb, is available commercially in the U.S. and over 15 other territories. Nicox generates revenue from ZERVIATE in allergic conjunctivitis, licensed in multiple geographies.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 1.19 | |||||
| Debt-to-EBITDA | -3.22 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -14.48 | |||||
| Beneish M-Score | -4.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -32.3 | |||||
| 3-Year EBITDA Growth Rate | 8 | |||||
| 3-Year EPS without NRI Growth Rate | 8 | |||||
| 3-Year Book Growth Rate | -46 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.52 | |||||
| 9-Day RSI | 58.52 | |||||
| 14-Day RSI | 59.76 | |||||
| 6-1 Month Momentum % | 4.52 | |||||
| 12-1 Month Momentum % | -45.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.46 | |||||
| Quick Ratio | 1.46 | |||||
| Cash Ratio | 0.82 | |||||
| Days Sales Outstanding | 101.76 | |||||
| Days Payable | 53.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.4 | |||||
| Shareholder Yield % | -5.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -74.3 | |||||
| Operating Margin % | -93.44 | |||||
| Net Margin % | -126.37 | |||||
| FCF Margin % | -83.81 | |||||
| ROE % | -43.58 | |||||
| ROA % | -20.5 | |||||
| ROIC % | -18.78 | |||||
| ROC (Joel Greenblatt) % | -4540 | |||||
| ROCE % | -20.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.66 | |||||
| PB Ratio | 0.91 | |||||
| Price-to-Tangible-Book | 0.88 | |||||
| EV-to-EBIT | -3.13 | |||||
| EV-to-EBITDA | -4.64 | |||||
| EV-to-Forward-EBITDA | -1.24 | |||||
| EV-to-Revenue | 3.42 | |||||
| EV-to-Forward-Revenue | 12.19 | |||||
| EV-to-FCF | -4.13 | |||||
| Price-to-Median-PS-Value | 0.12 | |||||
| Earnings Yield (Greenblatt) % | -31.96 | |||||
| FCF Yield % | -46.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nicox SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 9.992 | ||
| EPS (TTM) (€) | -0.235 | ||
| Beta | 0.36 | ||
| Volatility % | 80.74 | ||
| 14-Day RSI | 59.76 | ||
| 14-Day ATR (€) | 0.014269 | ||
| 20-Day SMA (€) | 0.2654 | ||
| 12-1 Month Momentum % | -45.8 | ||
| 52-Week Range (€) | 0.14 - 0.4915 | ||
| Shares Outstanding (Mil) | 63.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nicox SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nicox SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nicox SA Frequently Asked Questions
What is Nicox SA(XPAR:ALCOX)'s stock price today?
The current price of XPAR:ALCOX is €0.28. The 52 week high of XPAR:ALCOX is €0.49 and 52 week low is €0.14.
When is next earnings date of Nicox SA(XPAR:ALCOX)?
The next earnings date of Nicox SA(XPAR:ALCOX) is 2025-03-01 Est..
Does Nicox SA(XPAR:ALCOX) pay dividends? If so, how much?
Nicox SA(XPAR:ALCOX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers